Michael Salcius
Novartis (China)(CN)Novartis (United States)(US)Tris Pharma (United States)(US)
Publications by Year
Research Areas
RNA Research and Splicing, RNA modifications and cancer, Monoclonal and Polyclonal Antibodies Research, Neurogenetic and Muscular Disorders Research, Protein Degradation and Inhibitors
Most-Cited Works
- → SMN2 splice modulators enhance U1–pre-mRNA association and rescue SMA mice(2015)426 cited
- → Analyzing antibody specificity with whole proteome microarrays(2003)275 cited
- → Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer(2008)205 cited
- → DcpS as a Therapeutic Target for Spinal Muscular Atrophy(2008)131 cited
- → CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing’s sarcoma(2019)87 cited
- → Functional protein microarrays: just how functional are they?(2005)52 cited
- → Identification of Elongation Factor G as the Conserved Cellular Target of Argyrin B(2012)51 cited